CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Frazier adds $1.1B+ to small and mid-sized biotech fund

Positive
AI Analysis

Summary

Frazier Life Science Fund raised $1.1B+ for its small and mid-sized biotech fund. The fund's previous investments in Verona Pharma and Carmot Therapeutics were acquired by Merck for $10B and Roche for $2.7B, respectively.

Importance:5/10
Sentiment:
0.70
fund_raiseacquisitionmerckrocheverona_pharmacarmot_therapeutics
Related Companies

Read the original article

Published by BioSpace on September 11, 2026 12:25 PM

Read Original